Business / Finance

RSS

Covidien fourth quarter net sales increase 15% to $3.08 billion

Covidien plc today reported results for the fourth quarter of fiscal 2011.

15 Nov 2011

InVivo Therapeutics reports net income of $3,067,000 for third quarter 2011

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

15 Nov 2011

HemaCare reports third quarter revenue of $4.0M from continuing operations

HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.

14 Nov 2011

Cadence proposes $75M underwritten public offering of common stock

Cadence Pharmaceuticals, Inc. today announced its intention to offer and sell $75 million worth of shares of its common stock in an underwritten public offering.

14 Nov 2011

Bond Labs third fiscal quarter revenue increases 58%

Bond Laboratories, Inc., a national provider of innovative and proprietary nutritional supplements for health conscious consumers, today announced continued significant revenue growth and positive net income for the third fiscal quarter of 2011.

14 Nov 2011

Cyanotech second quarter revenues increase to $5,989,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2012, ended September 30, 2011.

14 Nov 2011

Corgenix first quarter total revenues increase 10.1% to $2.18 million

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its fiscal quarter Form 10-Q and reported financial results.

14 Nov 2011

ABMC third quarter net sales decrease 6.5% to $2,365,000

American Bio Medica Corporation today announced financial results for the three and nine months ended September 30, 2011.

14 Nov 2011

Bovie Medical third quarter revenues decrease marginally to $6.3 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter and nine months ended September 30, 2011.

14 Nov 2011

SANUWAVE Health third quarter revenues decrease 42% to $161,678

SANUWAVE Health, Inc. today reported financial results for the three and nine months ended September 30, 2011.

14 Nov 2011

Cortex third quarter net loss increases to $1,175,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.

14 Nov 2011

American Shared Hospital Services third quarter revenue increases to $9,148,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the third quarter and first nine months of 2011.

From Elekta 14 Nov 2011

Cord Blood America third quarter revenues increase 56% to $1.49 million

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced revenues for the nine months ended September 30, 2011 totaled $4.38 million, up 59 percent compared to revenues of $2.75 million in the same period in 2010.

14 Nov 2011

Simcere third quarter total revenue decreases 8.9% to RMB501.0 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.

14 Nov 2011

Sinovac third quarter sales increase 60.8% to $15.4 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.

14 Nov 2011

EntreMed third quarter net loss decreases to $1.3 million

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for the three and nine-month periods ending September 30, 2011.

14 Nov 2011

Soligenix third quarter revenues increase to $5,796,000

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the third quarter of 2011.

14 Nov 2011

Conmed Healthcare Management third quarter net revenue increases 17.4% to record $18.1M

Conmed Healthcare Management, Inc., a leading full service provider of correctional facility healthcare services to county and municipal detention centers, today announced financial results for the three- and nine-month periods ended September 30, 2011.

14 Nov 2011

Nile Therapeutics third quarter net loss decreases to $1.1 million

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its third quarter financial results for 2011.

14 Nov 2011

AB SCIEX acquires mass spectrometry business of Labindia Instruments

AB SCIEX, a global leader in life science analytical technologies, today announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd., a leading life science solutions service provider in India.

14 Nov 2011